PL89056B1 - - Google Patents

Download PDF

Info

Publication number
PL89056B1
PL89056B1 PL1972158392A PL15839272A PL89056B1 PL 89056 B1 PL89056 B1 PL 89056B1 PL 1972158392 A PL1972158392 A PL 1972158392A PL 15839272 A PL15839272 A PL 15839272A PL 89056 B1 PL89056 B1 PL 89056B1
Authority
PL
Poland
Prior art keywords
parts
weight
formula
carbonylamino
yield
Prior art date
Application number
PL1972158392A
Other languages
English (en)
Polish (pl)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of PL89056B1 publication Critical patent/PL89056B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D239/08—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
    • C07D239/10—Oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06—Anabolic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C07D233/38—One oxygen atom with acyl radicals or hetero atoms directly attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/34—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/10—Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
PL1972158392A 1971-10-23 1972-10-21 PL89056B1 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2152967A DE2152967C3 (de) 1971-10-23 1971-10-23 Acylureidopenicilline

Publications (1)

Publication Number Publication Date
PL89056B1 true PL89056B1 (enExample) 1976-10-30

Family

ID=5823251

Family Applications (2)

Application Number Title Priority Date Filing Date
PL1972183057A PL93574B1 (enExample) 1971-10-23 1972-10-21
PL1972158392A PL89056B1 (enExample) 1971-10-23 1972-10-21

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL1972183057A PL93574B1 (enExample) 1971-10-23 1972-10-21

Country Status (31)

Country Link
JP (2) JPS55391B2 (enExample)
AR (1) AR195805A1 (enExample)
AT (1) AT320152B (enExample)
BE (1) BE790440A (enExample)
BG (2) BG21609A3 (enExample)
CA (1) CA1019323A (enExample)
CH (1) CH579089A5 (enExample)
CS (1) CS188883B2 (enExample)
CY (1) CY947A (enExample)
DD (1) DD106044B3 (enExample)
DE (1) DE2152967C3 (enExample)
DK (1) DK134992C (enExample)
EG (1) EG10826A (enExample)
ES (1) ES407851A1 (enExample)
FI (1) FI56839C (enExample)
FR (1) FR2157908B1 (enExample)
GB (1) GB1392849A (enExample)
HK (1) HK18578A (enExample)
HU (1) HU167986B (enExample)
IE (1) IE37123B1 (enExample)
IL (1) IL40628A (enExample)
KE (1) KE2824A (enExample)
LU (1) LU66332A1 (enExample)
NO (1) NO143909C (enExample)
PH (1) PH9893A (enExample)
PL (2) PL93574B1 (enExample)
RO (2) RO60670A (enExample)
SE (1) SE412236B (enExample)
SU (1) SU527139A3 (enExample)
YU (1) YU264072A (enExample)
ZA (1) ZA727473B (enExample)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL175419C (nl) * 1971-10-23 1984-11-01 Bayer Ag Werkwijze ter bereiding of vervaardiging van antibiotisch werkzame farmaceutische preparaten, alsmede werkwijze ter bereiding van antibiotisch werkzame alfa-gesubstitueerde 6-(alfa-(3-acylureido)acetylamino) penicillanzuurderivaten.
US3972869A (en) * 1971-10-23 1976-08-03 Bayer Aktiengesellschaft Penicillins
US3972870A (en) * 1971-10-23 1976-08-03 Bayer Aktiengesellschaft Penicillins
US3978056A (en) * 1971-10-23 1976-08-31 Bayer Aktiengesellschaft Penicillins
US3983105A (en) * 1971-10-23 1976-09-28 Bayer Aktiengesellschaft Penicillins
US3974142A (en) * 1971-10-23 1976-08-10 Bayer Aktiengesellschaft Penicillins
US4009272A (en) * 1971-10-23 1977-02-22 Bayer Aktiengesellschaft Penicillins
US3974141A (en) * 1971-10-23 1976-08-10 Bayer Aktiengesellschaft Penicillins
DE2258973A1 (de) * 1972-12-01 1974-06-06 Bayer Ag Penicilline, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
JPS587637B2 (ja) * 1973-12-27 1983-02-10 住友化学工業株式会社 シンキペニシリンノ セイホウ
DE2407715C2 (de) * 1974-02-18 1982-12-02 Bayer Ag, 5090 Leverkusen Cephalosporine, Verfahren zu ihrer Herstellung sowie Arzneimittel
IL47168A (en) * 1974-05-09 1979-07-25 Toyama Chemical Co Ltd Mono or dioxo piperazino(thio)carbonylamino derivatives ofpenicillins and cephalosporins and process for producing the same
DE2525541C2 (de) * 1975-06-07 1984-01-12 Bayer Ag, 5090 Leverkusen β-Lactam-Antibiotica, Verfahren zu ihrer Herstellung sowie sie enthaltende Arzneimittel
DE2810083A1 (de) 1978-03-08 1979-09-20 Bayer Ag Beta-lactam-verbindungen
GB0420722D0 (en) 2004-09-17 2004-10-20 Addex Pharmaceuticals Sa Novel allosteric modulators
EP1780213A1 (en) * 2005-10-27 2007-05-02 3M Innovative Properties Company Silicon-urea-azolides, their preparation and use in the preparation of silicones with isocyanate terminal groups
AR059898A1 (es) 2006-03-15 2008-05-07 Janssen Pharmaceutica Nv Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
TW200845978A (en) 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
BRPI0816970A2 (pt) 2007-09-14 2015-03-24 Ortho Mcneil Janssen Pharm 1,3-dissubstituídas-4-fenil-1h-piridin-2-onas
EA017648B1 (ru) 2007-09-14 2013-02-28 Орто-Макнейл-Янссен Фармасьютикалз, Инк. 1',3'-двузамещенные-4-фенил-3,4,5,6-тетрагидро-2н,1'н-[1,4']бипириди-нил-2'-оны
TW200922566A (en) 2007-09-14 2009-06-01 Ortho Mcneil Janssen Pharm 1,3 disubstituted 4-(aryl-X-phenyl)-1H-pyridin-2-ones
CA2704436C (en) 2007-11-14 2016-01-05 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. Imidazo[1,2-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
JP5547194B2 (ja) 2008-09-02 2014-07-09 ジャンセン ファーマシューティカルズ, インコーポレイテッド. 代謝型グルタミン酸受容体の調節因子としての3−アザビシクロ[3.1.0]ヘキシル誘導体
WO2010043396A1 (en) 2008-10-16 2010-04-22 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
JP5690277B2 (ja) 2008-11-28 2015-03-25 ジャンセン ファーマシューティカルズ, インコーポレイテッド. 代謝型グルタミン酸受容体の調節因子としてのインドールおよびベンゾオキサジン誘導体
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
CN102439015B (zh) 2009-05-12 2015-05-13 杨森制药有限公司 1,2,4-三唑并[4,3-a]吡啶衍生物和其作为mGluR2受体的正向变构调节剂的用途
HRP20131122T1 (hr) 2009-05-12 2013-12-20 Janssen Pharmaceuticals, Inc. Derivati 1,2,4-triazolo[4,3-a] piridina i njihova uporaba u lijeäśenju ili prevenciji neuroloških i psihijatrijskih poremeä†aja
EP2440523A4 (en) * 2009-06-10 2014-03-19 Chongxi Yu COMPOSITION WITH STRONG PENETRATION OR PRODRUGS FROM ANTIMICROBIA AND COMPOUNDS IN ANTIMICROBIA
JP5852664B2 (ja) 2010-11-08 2016-02-03 ジヤンセン・フアーマシユーチカルズ・インコーポレーテツド 1,2,4−トリアゾロ[4,3−a]ピリジン誘導体およびmGluR2受容体のポジティブアロステリックモジュレーターとしてのそれらの使用
ES2536433T3 (es) 2010-11-08 2015-05-25 Janssen Pharmaceuticals, Inc. Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2
EP2661435B1 (en) 2010-11-08 2015-08-19 Janssen Pharmaceuticals, Inc. 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
JO3368B1 (ar) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
PL3096790T3 (pl) 2014-01-21 2020-01-31 Janssen Pharmaceutica, N.V. Kombinacje zawierające pozytywne modulatory allosteryczne lub agonistów ortosterycznych metabotropowego receptora glutaminergicznego podtypu 2 i ich zastosowanie
ME03518B (me) 2014-01-21 2020-04-20 Janssen Pharmaceutica Nv Kombinacije koje obuhvataju pozitivne alosterične modulatore ili ortosterične agoniste metabotropnog glutamatergičnog receptora podtipa 2 i njihova primjena

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1770620A1 (de) * 1968-06-12 1971-11-11 Bayer Ag Neue Penicilline

Also Published As

Publication number Publication date
KE2824A (en) 1978-04-07
SE412236B (sv) 1980-02-25
AT320152B (de) 1975-01-27
AR195805A1 (es) 1973-11-09
RO63066A (fr) 1978-06-15
GB1392849A (en) 1975-04-30
DD106044A5 (enExample) 1974-05-20
PH9893A (en) 1976-06-08
PL93574B1 (enExample) 1977-06-30
YU264072A (en) 1982-06-18
AU4806472A (en) 1974-04-26
CA1019323A (en) 1977-10-18
DD106044B3 (de) 1990-07-18
BG21609A3 (bg) 1976-07-20
FR2157908B1 (enExample) 1976-03-19
IL40628A (en) 1976-08-31
EG10826A (en) 1976-12-31
RO60670A (enExample) 1976-10-15
DE2152967C3 (de) 1981-11-19
BE790440A (enExample) 1973-04-24
ZA727473B (en) 1973-07-25
JPS4849910A (enExample) 1973-07-14
CS188883B2 (en) 1979-03-30
LU66332A1 (enExample) 1973-01-23
IE37123L (en) 1973-04-23
FI56839B (fi) 1979-12-31
HU167986B (enExample) 1976-02-28
JPS57843B2 (enExample) 1982-01-08
JPS55391B2 (enExample) 1980-01-08
HK18578A (en) 1978-04-14
SU527139A3 (ru) 1976-08-30
JPS4849787A (enExample) 1973-07-13
DE2152967B2 (de) 1981-02-19
IE37123B1 (en) 1977-05-11
DE2152967A1 (de) 1973-05-03
IL40628A0 (en) 1972-12-29
FI56839C (fi) 1980-04-10
ES407851A1 (es) 1975-10-01
BG20813A3 (bg) 1975-12-20
NO143909B (no) 1981-01-26
CY947A (en) 1978-06-23
DK134992B (da) 1977-02-21
DK134992C (da) 1977-07-18
FR2157908A1 (enExample) 1973-06-08
CH579089A5 (enExample) 1976-08-31
NO143909C (no) 1981-05-06

Similar Documents

Publication Publication Date Title
FI75825B (fi) Foerfarande foer framstaellning av -laktamantibiotika.
SE412236B (sv) Forfarande for framstellning av nya penicillinforeningar
US3687949A (en) Synthetic cephalosporins
US4386089A (en) β-Lactam antibiotics and their medicinal use
SE446536B (sv) Forfarande for framstellning av omettade derivat av 7-acylamido-3-cefem-4-karboxylsyra
CA1064020A (en) .beta.-LACTAM ANTIBIOTICS AND PROCESSES FOR THEIR PREPARATION AND USE
CA1122593A (en) .beta.-LACTAM COMPOUNDS, THEIR PRODUCTION AND THEIR MEDICINAL USE
US3996217A (en) 3-Triazolylthio derivatives of ureido cephalosporins
US4223037A (en) β-Lactam antibiotics and their use
PL81220B1 (en) Derivatives of 7-aminocephalosporanic acid[us3719673a]
US4009272A (en) Penicillins
US4438114A (en) β-Lactam antibiotics
US3757015A (en) Oxylic acids 7-(d-(alpha-amino-alpha-phenyl-, 2 - thienyl- and 3-thienyl-acetamido) - 3 - (s-(2-methyltetrazole - 5-yl)thiomethyl) - 3 - -cephem-4-carb
CA1070674A (en) Penicillins and processes for their preparation and use
US3960849A (en) Amino-1,2,4-oxadiazolyl-3-acetyl cephalosporins
US4208412A (en) β-Lactam antibiotics
US3983105A (en) Penicillins
US4110535A (en) 3-oxopyridazinylthiomethyl derivatives of ureidocephalosporins
US4294827A (en) Antibacterial and growth promoting β-lactam antibiotics carrying an -ylidene-2-pyrrolidinon-1-yl radical
US4128724A (en) Hydrazinocarbonylamino cephalosporins
US4401667A (en) Cephalosporins
CA1121809A (en) 7.beta.-[(2-AMINO-1,2-DIOXOETHYL)AMINO]ACYL CEPHALOSPORIN DERIVATIVES
CA1072079A (en) B-lactams and processes for their preparation and use
PL101400B1 (pl) Sposob wytwarzania nowych ureidocefalosporyn
KR830001656B1 (ko) B-락탐계 항생물질의 제조방법